BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  electroCore Strengthens its Global Management Team

  September 25, 2013

   · 

  1 min read
• Genetown

  BCC Research Publishes a New Report on Global Markets for Global Sensing Products

  September 25, 2013

   · 

  3 min read
• Biotech Beach

  Evoke Pharma, Inc. Announces Pricing of Initial Public Offering of 2,100,000 Shares of Common Stock

  September 25, 2013

   · 

  1 min read
• Business

  Response Genetics, Inc. Announces Contract With Three Rivers Provider Network

  September 25, 2013

   · 

  1 min read
• Drug Development

  Dynavax Technologies Corporation Release: Phase 3 Data on HEPLISAV™ in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE

  September 25, 2013

   · 

  2 min read
• Biotech Beach

  BIOLASE Technology, Inc. Announces $5 Million Registered Direct Offering

  September 25, 2013

   · 

  4 min read
• Pharm Country

  inVentiv Health Clinical Launches Physician Network for Late-Stage Research

  September 25, 2013

   · 

  7 min read
• Business

  Stellar Biotechnologies, Inc. Appoints Tessie Che, Ph.D. to Board of Directors

  September 25, 2013

   · 

  4 min read
• Drug Development

  Stemline Therapeutics, Inc. Announces Oral Presentation of SL-401, a Clinical-Stage Targeted Therapy, Demonstrating Notable Preclinical Activity in an Additional Indication, Chronic Myeloid Leukemia (CML), at the 15th International Conference on CML

  September 25, 2013

   · 

  1 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Completes Enrollment in Phase 3 VALOR Trial of Vosaroxin in AML

  September 25, 2013

   · 

  1 min read